ProCE Banner Series

Expert Updates on the Latest Advances in the Development of Weekly Insulin Formulations

Experts on the frontlines of insulin research and patient care will provide the latest evidence on weekly insulin formulation in this live, hybrid event. Faculty will cover the latest in weekly insulin formulations – including mechanisms, efficacy, and safety as well as addressing the anticipated needs of patients and providers, once these treatments are available.

To Register: In-Person AND Virtual attendees must be registered for EASD in order to attend.

Register for EASD at:  https://www.easd.org/annual-meeting/easd-2023.html#section-registration

If you are attending virtually, EASD will provide the log-in information with your registration confirmation.

Disclaimer: Industry session on the occasion of EASD 2023.


Who Should Attend

This program is intended for endocrinologists and scientists who are involved and/or related to research on new insulin development and the care of patients with diabetes.

All Events

Expert Updates on the Latest Advances in the Development of Weekly Insulin Formulations

Past Events

October

02

2023

3:30 PM - 5:00 PM Central European Summer Time (CEST)

In-personVirtual

Hamburg Messe + Congress, Messeplatz 1, 20357 Hamburg, Germany

Topics

  • Tracking the Evolution of Insulin and the Impetus for Change
  • Overview of Weekly Insulin Formulations in Development
  • The Latest Clinical Trial Data of Weekly Insulin Formulations
  • Practical Considerations and Addressing Concerns
  • Question and Answer Session

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Target Audience
This program is intended for endocrinologists and scientists who are involved and/or related to research on new insulin development and the care of patients with diabetes.

Goal Statement
The goal of this program is to improve the knowledge and competence of endocrinologists and scientists with the latest evidence on the mechanisms, efficacy, and safety of weekly insulin formulations in development and the potential for these treatments to address challenges with current insulin therapy and achievement of glycemic goals in patients with diabetes.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify challenges with daily basal insulin that may be overcome by weekly insulin formulations in development
  • Compare the mechanism of action, efficacy, and safety of weekly insulin formulations in development with available daily basal insulins
  • Evaluate strategies to address patient and provider barriers to implementing weekly insulins into clinical practice

Accreditation

This educational activity is not certified for CME/CE credit. 

Acknowledgement

Jointly provided by Clinical Care Options, LLC and Endocrine Society.

This activity is supported by an educational grant from Lilly.

Contact Clinical Care Options

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191